13F Holdings
中文EN

Frazier Life Sciences Management, L.P.

PALO ALTO CA · SEC CIK 0001892134

2026Q22026Q1 9 earlier quarters 🔒
$4.59B2026Q2 reported value
41Positions
73.6%Top 10 weight · largest 19.6%
3 / 3New / sold out
Reported value over time$4.59B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

MIRM 19.6%
NAMS 13.3%
ERAS 10.0%
MBX 8.0%
ARQT 5.6%
TRVI 4.0%
KRYS 3.9%
MAZE 3.3%
PHAT 2.9%
PVLA 2.9%

2026Q2 top buys estimated at quarter-end value

ACHV New+$49.72M
NAMS Added+$38.81M
ALLO Added+$38.79M
STTK New+$26.02M
ASND Reappeared+$24.49M

2026Q2 top sells estimated at quarter-end value

BBIO Reduced-$141.51M
KALVISTA PHARMAC Sold out-$99.87M
RVMD Sold out-$65.71M
AGIO Sold out-$42.49M
TRVI Reduced-$1,865

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
MIRM MIRUM PHARMACEUTICALS INC $899.06M19.58%7,679,684 00.0% — Unchanged
NAMS NEWAMSTERDAM PHARMA COMPANY $613.03M13.35%18,088,902 1,145,1286.8% $38.81M Added
ERAS ERASCA INC $457.55M9.96%24,975,188 300,0001.2% $5.50M Added
MBX MBX BIOSCIENCES INC $367.19M8.00%6,652,013 00.0% — Unchanged
ARQT ARCUTIS BIOTHERAPEUTICS INC $258.91M5.64%9,874,511 00.0% — Unchanged
TRVI TREVI THERAPEUTICS INC $185.37M4.04%9,939,447 -100-0.0% -$1,865 Reduced
KRYS KRYSTAL BIOTECH INC $178.89M3.90%481,307 00.0% — Unchanged
MAZE MAZE THERAPEUTICS INC $150.18M3.27%5,032,915 465,64110.2% $13.89M Added
PHAT PHATHOM PHARMACEUTICALS INC $135.26M2.95%12,466,489 00.0% — Unchanged
PVLA PALVELLA THERAPEUTICS INC NE $134.85M2.94%882,400 00.0% — Unchanged
BBIO BRIDGEBIO PHARMA INC $115.31M2.51%1,548,139 -1,900,000-55.1% -$141.51M Reduced
IRON DISC MEDICINE INC $99.09M2.16%1,354,852 00.0% — Unchanged
CYTK CYTOKINETICS INC $98.81M2.15%1,159,879 00.0% — Unchanged
DYN DYNE THERAPEUTICS INC $70.03M1.53%3,153,082 00.0% — Unchanged
ASND ASCENDIS PHARMA A/S $60.05M1.31%225,155 91,82268.9% $24.49M Reappeared
SVRA SAVARA INC $59.88M1.30%9,720,852 00.0% — Unchanged
PBLS PARABILIS MEDICINES INC $52.57M1.14%1,920,805 1,920,805— — First reported
AURA AURA BIOSCIENCES INC $50.41M1.10%7,100,000 2,000,00039.2% $14.20M Added
ACHV ACHIEVE LIFE SCIENCE INC $49.72M1.08%7,614,836 7,614,836— $49.72M New
VOR VOR BIOPHARMA INC $46.83M1.02%2,543,939 00.0% — Unchanged
ALLO ALLOGENE THERAPEUTICS INC $46.69M1.02%22,446,668 18,650,000491.2% $38.79M Added
TARS TARSUS PHARMACEUTICALS INC $45.86M1.00%728,644 00.0% — Unchanged
BCRX BIOCRYST PHARMACEUTICALS INC $40.09M0.87%4,009,240 00.0% — Unchanged
ALKS ALKERMES PLC $36.71M0.80%700,647 00.0% — Unchanged
ACAD ACADIA PHARMACEUTICALS INC $36.39M0.79%1,438,198 00.0% — Unchanged
ZLAB ZAI LAB LTD $36.14M0.79%1,902,320 00.0% — Unchanged
MNKD MANNKIND CORP $28.12M0.61%6,600,000 700,00011.9% $2.98M Added
DSGN DESIGN THERAPEUTICS INC $26.19M0.57%1,809,854 1,288,854247.4% $18.65M Reappeared
ACRS ACLARIS THERAPEUTICS INC $26.06M0.57%4,925,374 00.0% — Unchanged
STTK SHATTUCK LABS INC $26.02M0.57%3,750,000 3,750,000— $26.02M New
KLRA KAILERA THERAPEUTICS INC $24.23M0.53%1,100,000 1,100,000— — First reported
GLUE MONTE ROSA THERAPEUTICS INC $24.20M0.53%1,000,000 00.0% — Unchanged
LXEO LEXEO THERAPEUTICS INC $22.46M0.49%4,824,725 400,0009.0% $1.86M Added
RLAY RELAY THERAPEUTICS INC $19.00M0.41%1,015,693 1,015,693— $19.00M New
EOLS EVOLUS INC $18.26M0.40%2,630,665 00.0% — Unchanged
IMCR IMMUNOCORE HLDGS PLC $15.39M0.34%484,782 00.0% — Unchanged
— VALNEVA SE $11.99M0.26%2,291,666 00.0% — Unchanged
— NEWAMSTERDAM PHARMA COMPANY $10.69M0.23%500,333 00.0% — Unchanged
AUTL AUTOLUS THERAPEUTICS LTD $7.12M0.15%4,447,910 00.0% — Unchanged
— XILIO THERAPEUTICS INC $4.05M0.09%422,505 00.0% — Unchanged
— IBIO INC $3.42M0.07%1,953,467 00.0% — Unchanged
— KALVISTA PHARMACEUTICALS INC $00.00%0 -4,961,108-100.0% -$99.87M Sold out
RVMD REVOLUTION MEDICINES INC $00.00%0 -675,686-100.0% -$65.71M Sold out
AGIO AGIOS PHARMACEUTICALS INC $00.00%0 -1,256,080-100.0% -$42.49M Sold out